# VALENTX INC: Form D filings

VALENTX INC, a biotechnology company in Maple Grove, MN, filed 5 Form D notices with the SEC between 2009 and 2019. The latest, on February 19, 2019, reports $2 million sold of a $5.3 million offering to 3 investors.

Find out what VALENTX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VALENTX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VALENTX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fvalentx-inc-1220832)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VALENTX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VALENTX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fvalentx-inc-1220832)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6901 E. FISH LAKE ROAD, STE. 118, Maple Grove, MN, 55369
- Phone: (763) 222-1560
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1220832

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 19, 2019 | New notice | $5,250,000 | $1,971,260 | $3,278,740 | 3 | Feb 1, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1220832/000161559419000003/0001615594-19-000003-index.htm) |
| Aug 16, 2018 | New notice | Indefinite | $10,271,050 | Indefinite | 32 | Jul 25, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1220832/000161559418000039/0001615594-18-000039-index.htm) |
| Sep 3, 2015 | Amendment | $7,500,000 | $7,500,000 | $0 | 21 | Jul 15, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1220832/000161559415000111/0001615594-15-000111-index.htm) |
| Jul 28, 2014 | New notice | $7,500,000 | $4,111,767 | $3,388,233 | 20 | Jul 15, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1220832/000136211814000109/0001362118-14-000109-index.htm) |
| Aug 27, 2009 | New notice | $20,288,949 | $20,288,949 | $0 | 24 | Aug 18, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1220832/000136211809000034/0001362118-09-000034-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Elling Halvorson | Director |  |
| Paul LaViolette | Director |  |
| Bobby Griffin | Director |  |
| Jack Ahrens | Director |  |
| Jon St. Germain | Executive Officer, Director |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of Feb 18, 2019](https://specstream.ai/data/form-d/week/2019-02-18) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what VALENTX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).